Ramucirumab plus erlotinib versus placebo plus erlotinib in previously untreated EGFR-mutated metastatic non-small-cell lung cancer (RELAY): exploratory analysis of next-generation sequencing results

  1. Garon, E.B.
  2. Reck, M.
  3. Nishio, K.
  4. Heymach, J.V.
  5. Nishio, M.
  6. Novello, S.
  7. Paz-Ares, L.
  8. Popat, S.
  9. Aix, S.P.
  10. Graham, H.
  11. Butts, B.D.
  12. Visseren-Grul, C.
  13. Nakagawa, K.
Aldizkaria:
ESMO Open

ISSN: 2059-7029

Argitalpen urtea: 2023

Alea: 8

Zenbakia: 4

Mota: Artikulua

DOI: 10.1016/J.ESMOOP.2023.101580 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus